Education

Join Visiopharm for our webinar, “HER2 Protein Expression in Breast Cancer: Membrane Morphology and Accuracy with Regard to Gene Amplification” presented by Michael Grunkin, PhD the CEO and co-founder of Visiopharm. Date:     Monday,...

"We've been innovative to provide a much better pathology service for our patients. We're not going to stop there . . . our vision is that pathology really is the heart of a patient's diagnosis."   ​​– Dr. Sylvia...

Source: Dark Daily 7 May 2014 Prenatal testing, the most popular in China, is banned, affecting current projects at providers—another lesson for laboratories in how quickly things change Genetic testing has been halted in China. This...

Presenters: Dr. Bernard Fox, Endowed Chair and Chief, Laboratory of Molecular and Tumor Immunology Providence Cancer Center Dr. Carlo Bifulco, Director of Molecular Pathology and Pathology Informatics Providence Regional...

On February 6, 2014, the Department of Health and Human Services (HHS) released a final amendment to both CLIA 1988 and HIPAA 1996 rules in order to allow patients direct access to their lab results. In CLIA Final Rule 42 CFR 493.1291,...

OR

platinum partners

gold partners

Silver Partners

Media Partners